BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Synt:em

Below is an extended Synt:em research listing. Click here to return to the Synt:em main Biocorporate entry.

Recent Publications by Synt:em:

Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 2. Cationic peptide vectors for brain delivery.
BACKGROUND: SynB family peptides conjugated to several drugs have been...
17th March, 2007
Synt:em, Chemotherapy. 2007;53(1):73-6. Epub 2007 Jan 3.
DOI Direct Link
Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 1. Anti-infective drugs.
Except for a few well-documented CNS therapeutics, quantitative data on...
17th March, 2007
Synt:em, Chemotherapy. 2007;53(1):70-2. Epub 2007 Jan 3.
DOI Direct Link
Improved brain uptake and pharmacological activity profile of morphine-6-glucuronide using a peptide vector-mediated strategy.
Morphine-6-glucuronide (M6G), an active metabolite of morphine, has been...
6th July, 2005
Synt:em, Parc Scientifique Georges Besse, Nimes, France. J Pharmacol Exp Ther. 2005 May;313(2):712-9. Epub 2005 Jan 12.
DOI Direct Link
Peptide-vector strategy bypasses P-glycoprotein efflux, and enhances brain transport and solubility of paclitaxel.
We present the results obtained with paclitaxel coupled to a...
29th June, 2005
Synt:em, Institut de Genetique Moleculaire de Montpellier, CNRS UMR 5535, Anticancer Drugs. 2004 Nov;15(10):947-54.
The use of cell-penetrating peptides for drug delivery.
In the past decade, several peptides that can translocate cell membranes...
22nd December, 2004
Synt:em, Parc Scientifique Georges Besse, 30000 Nimes, France. Drug Discov Today. 2004 Dec 1;9(23):1012-9.
DOI Direct Link
Cheminformatics--decision making in drug discovery.
Biological membranes normally restrict the passage of hydrophilic...
1st October, 2004
Vice President R&D, Computational Drug Discovery, Synt:em, Parc Drug Discov Today. 2002 Sep 1;7(17):898-900.
2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistance.
A well-known mechanism leading to the emergence of multidrug-resistant...
19th August, 2004
Synt:em, Parc Scientifique Georges Besse, 30000 Nimes, France. Anticancer Drugs. 2004 Jul;15(6):609-17.
D-LogP: an alignment-free 3D description of local lipophilicity for QSAR studies.
The major hurdle to overcome in the development of 3D-QSAR models using...
29th July, 2004
Synt:em, Nimes, France. Methods Mol Biol. 2004;275:215-60.
DOI Direct Link
Blood-brain barrier permeation models: discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates.
The aim of this article is to present the design of a large heterogeneous...
20th March, 2004
Synt:em, Parc Scientifique G Besse, 30000 Nimes, France. J Chem Inf Comput Sci. 2004 Jan-Feb;44(1):239-48.
DOI Direct Link
Peptide vectors as drug carriers.
The aim of this article is to present the design of a large heterogeneous...
30th January, 2004
Synt:em, Parc Scientifique Georges Besse, 30000 Nimes, France. Prog Drug Res. 2003;61:221-38.
Studies on the internalization mechanism of cationic cell-penetrating peptides.
A great deal of data has been amassed suggesting that cationic peptides...
11th November, 2003
Synt:em, Institut de Genetique Moleculaire, 1919 Route de Mende, 34293 J Biol Chem. 2003 Aug 15;278(33):31192-201. Epub 2003 Jun 3.
DOI Direct Link
A peptide mimetic of an anti-CD4 monoclonal antibody by rational design.
The development of rational methods to design 'continuous' sequence...
4th September, 2003
Synt:em, Parc Scientifique Georges Besse, FR-30035 1, Ni;mes Cedex, Biochem Biophys Res Commun. 2003 Jul 18;307(1):198-205.
Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy.
The blood-brain barrier restricts the passage of substances into the...
25th July, 2003
Synt:em, Parc Scientifique Georges Besse, 30000 Nimes, France. J Pharmacol Exp Ther. 2003 Jul;306(1):371-6. Epub 2003 Apr 7.
DOI Direct Link
Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors.
Biological membranes normally restrict the passage of hydrophilic...
1st April, 2003
Synt:em, Parc Scientifique Georges Besse, Nimes, France. AAPS PharmSci. 2002;4(4):E26.
DOI Direct Link
Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy.
Previous studies from our laboratory have demonstrated that the coupling...
27th December, 2002
Synt:em, Parc Scientifique Georges Besse, Nimes, France. J Drug Target. 2002 Jun;10(4):309-15.

«Synt:em

This page contained an extended Synt:em research listing. Click here to return to the Synt:em main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.